BioCentury
ARTICLE | Clinical News

Trabectedin regulatory update

February 16, 2009 8:00 AM UTC

Swissmedic approved Yondelis trabectedin from PharmaMar to treat soft tissue sarcoma (STS). PharmaMar already markets the cytotoxic alkaloid that binds the minor groove of DNA in the EU for STS, and ...